Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22617788 | 0.91 | KDM4E (0.33) | KDM4E | |
| SCHEMBL17189522 | 0.91 | SMN1; SMN2 (0.34) | PRKDCAHRKDM4EMEN1ALDH1A1 | |
| SCHEMBL12158912 | 0.89 | PRKDC (0.31) | PRKDCALDH1A1 | |
| SCHEMBL15888853 | 0.89 | KDM4E (0.38) | KDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL17248447 | 0.89 | PLA2G2A (0.36) | PRKDCAHRKDM4EMEN1ALDH1A1 | |
| SCHEMBL23738685 | 0.88 | AHR (0.35) | PRKDCAHRPTGER4KDM4EMEN1 | |
| SCHEMBL15888846 | 0.88 | KDM4E (0.35) | KDM4EALDH1A1EDNRBEDNRA | |
| SCHEMBL18120394 | 0.88 | PRKDC (0.39) | PRKDCAHRPTGER4KDM4EMEN1 | |
| SCHEMBL23468817 | 0.87 | ALDH1A1 (0.35) | KDM4EALDH1A1MAPTHPGDEDNRB | |
| SCHEMBL26510669 | 0.87 | PRKDC (0.35) | PRKDCAHRKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, ELOVL1, CRY1 | PRKDC 3901/4885AHR 2363/4885PTGER4 2482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.